Unione Europea -
italiano -
EMA (European Medicines Agency)
tecvayli
janssen-cilag international n.v. - teclistamab - mieloma multiplo - agenti antineoplastici - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tecvayli 30 mg/3 ml soluzione iniettabile
janssen-cilag ag - teclistamabum - soluzione iniettabile - teclistamabum 30 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 0.75 mg. - multipli myelom - biotechnologika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tecvayli 153 mg/1.7 ml soluzione iniettabile
janssen-cilag ag - teclistamabum - soluzione iniettabile - teclistamabum 153 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.43 mg. - multipli myelom - biotechnologika
Unione Europea -
italiano -
EMA (European Medicines Agency)
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - mieloma multiplo - agenti antineoplastici - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
blenrep 100 mg polvere per concentrato per soluzione per infusione
glaxosmithkline ag - belantamabum mafodotinum - polvere per concentrato per soluzione per infusione - praeparatio cryodesiccata: belantamabum mafodotinum 100 mg, natrii citras dihydricus, acidum citricum, trehalosum dihydricum, dinatrii edetas, polysorbatum 80, pro vitro corresp. natrium 3.15 mg. - multipli myelom - biotechnologika
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
terbinafina eurogenerici
eg s.p.a. - terbinafina - terbinafina